Glucose - A sweet way to die: Metabolic switching modulates tumor cell death

Cell Cycle

Volumn 11, Issue 21, 2012, Pages 3919-3925

  MacFarlane, Marion ^a   Robinson, Gemma L ^a   Cain, Kelvin ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Aerobic glycolysis; Apoptosis; Mitochondria; Oxidative phosphorylation; TRAIL; Tumor cell death

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CASPASE 3; CASPASE 8; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GLUCOSE; GLUTAMINE; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; OBATOCLAX; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P53; PYRUVIC ACID; TAMOXIFEN;

ANAEROBIC GLYCOLYSIS; CELL DEATH; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; HUMAN; IMMUNOBLOTTING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN CLEAVAGE; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 84869445913     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21804     Document Type: Review

References (28)

1. Dickens LS, Powley IR, Hughes MA, MacFarlane M. The 'complexities' of life and death: death receptor signalling platforms. Exp Cell Res 2012; 318:1269-77; PMID:22542855; http://dx.doi.org/10.1016/j.yexcr.2012.04.005.
2. MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, et al. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 2002; 21:6809-18; PMID:12360407; http://dx.doi.org/10.1038/sj.onc.1205853.
3. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124:269-70; PMID:13351639.
4. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7:11-20; PMID:18177721; http://dx.doi.org/10.1016/j.cmet.2007.10.002.
5. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.
6. Robinson GL, Dinsdale D, Macfarlane M, Cain K. Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL. Oncogene 2012; PMID:22310286; http://dx.doi.org/10. 1038/onc.2012.13.
7. Gillissen B, Wendt J, Richter A, Richter A, Müer A, Overkamp T, et al. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma. J Cell Biol 2010; 188:851-62; PMID:20308427; http://dx.doi.org/10.1083/jcb.200912070.
8. Yamaguchi R, Janssen E, Perkins G, Ellisman M, Kitada S, Reed JC. Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy. PLoS One 2011; 6:e24102; PMID:21949692; http://dx.doi.org/10.1371/ journal.pone.0024102.
9. Zagorodna O, Martin SM, Rutkowski DT, Kuwana T, Spitz DR, Knudson CM. 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. Oncogene 2012; 31:2738-49; PMID:21986940; http://dx.doi.org/10.1038/ onc.2011.454.
10. Merino R, Ding L, Veis DJ, Korsmeyer SJ, Nuñez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994; 13:683-91; PMID:8313913.
11. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577-90; PMID:14651849; http://dx.doi.org/10.1016/S0092-8674(03)00929-2.
12. Sutherland C. What Are the bona fide GSK3 Substrates? Int J Alzheimers Dis 2011; 2011:505607; PMID:21629754.
13. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006; 21:749-60; PMID:16543145; http://dx.doi.org/10.1016/j.molcel.2006.02.009.
14. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116:1175-86; PMID:12615961; http://dx.doi.org/10.1242/ jcs.00384.
15. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102:8204-9; PMID:15928081; http://dx.doi.org/10.1073/ pnas.0502857102.
16. Maddocks ODK, Vousden KH. Metabolic regulation by p53. J Mol Med (Berl) 2011; 89:237-45; PMID:21340684; http://dx.doi.org/10.1007/s00109-011-0735-5.
17. Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi AA. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget 2011; 2:948-57; PMID:22248668.
18. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science 2006; 312:1650-3; PMID:16728594; http://dx.doi.org/10.1126/science.1126863.
19. Martínez-Paniagua MA, Baritaki S, Huerta-Yepez S, Ortiz-Navarrete VF, González-Bonilla C, Bonavida B, et al. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis. Cell Cycle 2011; 10:2792-805; PMID:21822052; http://dx.doi.org/10.4161/ cc.10.16.16952.
20. Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR, et al. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Res 2011; 71:5204-13; PMID:21670080; http://dx.doi.org/10.1158/0008-5472.CAN-10-4531.
21. Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A, et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24:1348-58; PMID:15608680; http://dx.doi.org/10.1038/sj.onc.1208300.
22. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412:179-90; PMID:18466115; http://dx.doi.org/10.1042/BJ20080281.
23. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30:214-26; PMID:18439900; http://dx.doi.org/10.1016/j.molcel.2008.03.003.
24. Zhong D, Liu X, Schafer-Hales K, Marcus AI, Khuri FR, Sun SY, et al. 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther 2008; 7:809-17; PMID:18413794; http://dx.doi.org/10.1158/1535- 7163.MCT-07-0559.
25. Ramírez-Peinado S, Alcázar-Limones F, Lagares-Tena L, El Mjiyad N, Caro-Maldonado A, Tirado OM, et al. 2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res 2011; 71:6796-806; PMID:21911456; http://dx.doi.org/10.1158/0008-5472.CAN-11-0759.
26. Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, Wang C, et al. Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 2011; 10:2521-8; PMID:21768775; http://dx.doi.org/10.4161/cc.10.15.16584.
27. Panieri E, Toietta G, Mele M, Labate V, Ranieri SC, Fusco S, et al. Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage. Aging (Albany NY) 2010; 2:487-503; PMID:20739737.
28. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009; 9:563-75; PMID:19629071; http://dx.doi.org/10.1038/nrc2676.